Select a Country Investors News Media Gallery Contact About Alexion Patient Focus Products Research and Development Careers No is a word they’ve heard too often. Most patients with severe and life-threatening rare diseases live with no effective treatment options and no hope. We develop and deliver treatments that will dramatically transform their lives. Patient Stories We work relentlessly... Our entire global organization is focused on bringing breakthrough therapies to patients in need. Today, we are serving patients in nearly 50 countries and advancing the most robust pipeline of innovative therapies in our history. Latest News view all news Featured Stories view all stories Alexion Reveals Plans for Future Expansion in Ireland Building Our Future Global Headquarters Making dramatic discoveries for patients with severe and life-threatening diseases. Our development pipeline is focused on highly innovative therapies with the potential to transform the lives of patients with devastating diseases who are often overlooked because of the rarity of their disorders. Research and Development Because if they ask whether there’s a treatment... Our global team is driven to provide patients with hope. Products We need to tell them yes. Every day we challenge ourselves to reach the ultimate goal of telling patients, “Yes,” there is a treatment. “Yes,” you will have access to it. And “Yes,” we’ll continue to serve patients by introducing new life-transforming treatments worldwide. Careers © 2014 Alexion Legal|Privacy Policy|Terms of Use|Site Map Please see Full Prescribing Information and Important Safety Information for Soliris® (eculizumab). This website is intended only for residents of the United States.

Select a Country Investors News Media Gallery Contact About Alexion Patient Focus Products Research and Development Careers Home » About Alexion » Leadership Leadership Management Team Leonard Bell, M.D. Chief Executive Officer Stephen Squinto, Ph.D., Executive Vice President, Chief Global Operations Officer David Hallal, Executive Vice President, Chief Commercial Officer Martin Mackay, Ph.D., Executive Vice President, Global Head of Research & Development Vikas Sinha, Executive Vice President, Chief Financial Officer Clare Carmichael, Senior Vice President, Chief Human Resources Officer Saqib Islam Senior Vice President, Chief Strategy and Portfolio Officer Edward Miller, Senior Vice President, Global Chief Compliance Officer John Moriarty, Senior Vice President, General Counsel Board of Directors Max Link, Ph.D., Chairman of the Board of Directors Leonard Bell, M.D., Chief Executive Officer David R. Brennan, Director M. Michele Burns, Director Christopher J. Coughlin, Director William Keller, Director John T. Mollen, Director R. Douglas Norby, Director Alvin S. Parven, Director Andreas Rummelt, Ph.D., Director Ann Veneman, Director Leadership Global Presence Partnering Milestones In Our Communities Awards & Recognition © 2014 Alexion Legal|Privacy Policy|Terms of Use|Site Map Please see Full Prescribing Information and Important Safety Information for Soliris® (eculizumab). This website is intended only for residents of the United States.